53 studies found for:    " September 15, 2009":" October 15, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" September 15, 2009":" October 15, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (53 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
2 Completed Profile of HIV Seropositive Patients
Conditions: HIV Infection;   HIV Infections
Intervention:
3 Completed The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: Shang Ring circumcision
4 Completed Genotype Based Personalized Prescription of Nevirapine
Conditions: Nevirapine Induced Rash;   Nevirapine Induced Hepatitis;   HIV;   Adverse Side Effects;   AIDS;   HIV Infections
Interventions: Genetic: Genetic test for NVP induced rash;   Other: 3TC/D4T/NVP or 3TC/AZT/NVP
5 Active, not recruiting Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Conditions: Immune Reconstitution Inflammatory Syndrome;   HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: Placebo
6 Active, not recruiting TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents
Conditions: HIV Infections;   HIV-1
Intervention: Drug: Etravirine
7 Completed Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
Conditions: HIV Prevention;   HIV Infections
Interventions: Drug: Tenofovir;   Drug: HEC Placebo;   Drug: Open label tenofovir tablet
8 Completed Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
9 Unknown  Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Drug: lopinavir/ritonavir plus maraviroc
10 Completed Europe-Africa Research Network for Evaluation of Second-line Therapy
Conditions: Human Immunodeficiency Virus;   HIV
Interventions: Drug: Aluvia + 2NRTIs;   Drug: Aluvia + raltegravir;   Drug: Aluvia monotherapy
11 Completed Study of Vitamin D Supplementation to Male HIV Sero-positive Patients
Condition: HIV Seropositive
Interventions: Drug: Rocaltrol;   Drug: Vitamin D;   Drug: Calcium
12 Completed QoL and Adherence to One-pill Once-a-day HAART
Conditions: HIV Infection;   HIV Infections
Intervention: Other: reduced number of pills
13 Completed Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: maraviroc;   Drug: darunavir;   Drug: ritonavir
14 Completed The St. Marys and The Mater Switch Study
Condition: HIV Infections
Intervention: Drug: Maraviroc
15 Completed The Women's HIV SeroIncidence Study (ISIS)
Condition: HIV Infections
Intervention:
16 Active, not recruiting Using Heavy Water to Study Cell Dynamics in Parkinson's Disease
Conditions: Parkinson's Disease;   HIV Infections
Intervention:
17 Completed HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program
Condition: HIV Infections
Intervention:
18 Completed Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy
Condition: HIV Infections
Interventions: Biological: WT-gag-TCR modified T cells;   Biological: α/6-gag-TCR modified T cells;   Other: STI or Drug Holiday
19 Unknown  Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
Condition: HIV Infections
Intervention: Drug: maraviroc (Selzentry)
20 Completed Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults
Condition: HIV Infections
Interventions: Biological: PENNVAX-B;   Biological: IL-12 DNA plasmids

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years